A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, and Safety of LNP1955 in Patients with Moderate-to-Severe Plaque Psoriasis II.

Trial Profile

A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, and Safety of LNP1955 in Patients with Moderate-to-Severe Plaque Psoriasis II.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs LNP 1955 (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Lupin
  • Most Recent Events

    • 27 Oct 2017 Status changed from recruiting to completed.
    • 13 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top